ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

Cancer Meetings Listed

April 15, 1994

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994

Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc

December 2, 1977

60 Minutes Report “Deception at Duke” Wins Peabody Award

March 29, 2013